Cancer “envy” campaign attracts complaintsBMJ 2014; 348 doi: https://doi.org/10.1136/bmj.g1465 (Published 11 February 2014) Cite this as: BMJ 2014;348:g1465
- Zosia Kmietowicz
The tactics used by a UK charity to try to raise the profile of pancreatic cancer have been condemned for pitting one type of cancer against another.
The “envy” campaign devised by Pancreatic Cancer Action centred on the poor survival of people with pancreatic cancer: 3% of patients with pancreatic cancer but 97% of those with testicular cancer and 85% of those with breast cancer survive five years after diagnosis.
The advertisements, which appeared in the …